Lawrence Deng
About Lawrence Deng
Lawrence Deng is the VP & GM of GPS China at Bristol Myers Squibb, based in Shanghai, China, with extensive experience in pharmaceutical manufacturing and operations management across Asia.
Title and Current Role
Lawrence Deng currently holds the position of Vice President and General Manager, GPS China, at Bristol Myers Squibb. Based in Shanghai, China, he is responsible for overseeing the company's operations in the Chinese market.
Professional Background
Lawrence Deng has an extensive professional background that spans over two decades in the pharmaceutical industry. He has held key roles at several major companies, including Bristol Myers Squibb, Johnson & Johnson, and Wyeth Pharmaceuticals. His experience covers a wide range of responsibilities, from managing supply chain operations to leading manufacturing plants across Asia.
Previous Roles and Experience
Before his current role, Lawrence served as General Manager, GPS China, at Bristol Myers Squibb from 2020 to 2022. He also worked with Johnson & Johnson in various capacities from 2014 to 2020, including as Manufacturing Cluster Lead - Asia Pacific and General Manager of Xi'an Janssen Pharmaceutical Ltd. Earlier in his career, he held significant positions at Pfizer Nutritionals and Wyeth Pharmaceuticals in Singapore.
Education and Expertise
Lawrence Deng completed his Master's in Industrial & System Engineering and a Bachelor's Degree in Mechanical Engineering at the National University of Singapore. His academic background provided a strong foundation for his career in industrial management and operations within the pharmaceutical industry.
Key Contributions and Leadership
Throughout his career, Lawrence has led the establishment of multiple greenfield projects in the pharmaceutical manufacturing sector. He played a key role in the operational integration during the merger of Pfizer Nutritionals and Wyeth Nutrition. Additionally, he has contributed to significant improvements in production efficiency and cost reduction at Wyeth Pharmaceuticals Singapore.